Durán-Valle et al., 2014 - Google Patents
Identification of clinical yeasts by Vitek MS system compared with API ID 32 CDurán-Valle et al., 2014
View HTML- Document ID
- 14746811389665618925
- Author
- Durán-Valle M
- Sanz-Rodríguez N
- Muñoz-Paraíso C
- Almagro-Moltó M
- Gómez-Garcés J
- Publication year
- Publication venue
- Sabouraudia
External Links
Snippet
We performed a clinical evaluation of the Vitek MS matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI–TOF MS) system with the commercial database version 2.0 for rapid identification of medically important yeasts as compared with …
- 240000004808 Saccharomyces cerevisiae 0 title abstract description 70
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
- C12Q1/6895—Hybridisation probes for detection or identification of organisms for plants, fungi, or algae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chao et al. | Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts | |
| Cassagne et al. | Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory | |
| Dhiman et al. | Performance and cost analysis of matrix-assisted laser desorption ionization–time of flight mass spectrometry for routine identification of yeast | |
| Sendid et al. | Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals | |
| Vidal-Acuña et al. | Identification of clinical isolates of Aspergillus, including cryptic species, by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). | |
| Marklein et al. | Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates | |
| Zhao et al. | Yeast identification by sequencing, biochemical kits, MALDI–TOF MS and rep-PCR DNA fingerprinting | |
| Cassagne et al. | Performance of MALDI‐TOF MS platforms for fungal identification | |
| Halwachs et al. | Critical issues in mycobiota analysis | |
| Alshawa et al. | Successful identification of clinical dermatophyte and Neoscytalidium species by matrix-assisted laser desorption ionization–time of flight mass spectrometry | |
| Cassagne et al. | Routine identification and mixed species detection in 6,192 clinical yeast isolates | |
| Hayette et al. | Clinical evaluation of the DermaGenius® Nail real-time PCR assay for the detection of dermatophytes and Candida albicans in nails | |
| Lacroix et al. | Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species | |
| Borman et al. | Molecular identification of pathogenic fungi | |
| Byadarahally Raju et al. | Isolation and identification of Candida from the oral cavity | |
| Imbert et al. | Multi-centric evaluation of the online MSI platform for the identification of cryptic and rare species of Aspergillus by MALDI-TOF | |
| Packeu et al. | Identification of the Trichophyton mentagrophytes complex species using MALDI-TOF mass spectrometry | |
| Coulibaly et al. | Pseudallescheria/Scedosporium complex species identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry | |
| Carolis et al. | Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP | |
| Meason-Smith et al. | Panfungal polymerase chain reaction for identification of fungal pathogens in formalin-fixed animal tissues | |
| McCarthy et al. | PCR methodology and applications for the detection of human fungal pathogens | |
| Hall et al. | Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species | |
| Lorch et al. | Rapid polymerase chain reaction diagnosis of white-nose syndrome in bats | |
| Barker et al. | Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory | |
| Eddouzi et al. | Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals |